摘要
中医药在肺癌治疗中应用广泛,循证实践有助于中医诊疗决策科学化。通过对中医药治疗肺癌临床研究和meta分析的系统梳理,分析中医药物疗法和非药物疗法在肺癌治疗中的优缺点,总结中医药治疗肺癌领域的循证医学研究成果,为今后优化肺癌的中医治疗方案提供参考。
Traditional Chinese medicine (TCM) is widely used in the treatment of lung cancer,and evidence-based practice is helpful for scientific decision-making in diagnosis and treatment of TCM.Based on the systematic review of clinical research and meta-analysis of TCM for lung cancer,the advantages and disadvantages of TCM pharmacotherapy and non-pharmacotherapy in the treatment of lung cancer were analyzed,and the evidence-based medical research results in the treatment of lung cancer by TCM were summarized.It provides a reference for optimizing TCM treatment for lung cancer in the future.
作者
姚嘉麟
焦丽静
许玲
YAO Jialin;JIAO Lijing;XU Ling(Department of Oncology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China)
出处
《世界临床药物》
2021年第5期325-329,共5页
World Clinical Drug
基金
2019国家中医药管理局中医药循证能力建设项目(2019XZZX-ZL004)
上海市申康发展中心、上海申康医院发展中心临床三年行动计划项目(SHDC2020CR1052B)
上海市科委“科技创新行动计划”医学创新研究专项(20Y21902000)
上海市卫健委中西医临床协作试点项目(ZXYXZ-201901)
2019年度上海中医药大学预算内科研项目(2019LK026)。
关键词
中医药
药物疗法
非药物疗法
肺癌
循证医学
traditional Chinese medicine
pharmacotherapy
non-pharmacotherapy
lung cancer
evidence-based medicine
